MEDICINOVA, INC. Write off of Deferred Debt Issuance Cost
MEDICINOVA, INC. (MNOV) reported Write off of Deferred Debt Issuance Cost of $492.71 thousand for the 132-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2011-11-14
- MEDICINOVA, INC. write off of deferred debt issuance cost for the quarter ending 2011-09-30 was -$1.04K.
- MEDICINOVA, INC. write off of deferred debt issuance cost for the quarter ending 2011-06-30 was $493.75K.
- MEDICINOVA, INC. write off of deferred debt issuance cost for the quarter ending 2010-09-30 was $0.00.
- MEDICINOVA, INC. write off of deferred debt issuance cost for the quarter ending 2010-06-30 was $0.00.
| Period end | Write off of Deferred Debt Issuance Cost 3 month | Write off of Deferred Debt Issuance Cost 6 month | Write off of Deferred Debt Issuance Cost 9 month | Write off of Deferred Debt Issuance Cost 129 month | Write off of Deferred Debt Issuance Cost 132 month |
|---|---|---|---|---|---|
| 2011-09-30 | -$1.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $492.71K derived: sum of 2 quarters · filed 2011-11-14 | $492.71K 10-Q · filed 2011-11-14 | $492.71K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $493.75K 10-Q · filed 2011-08-15 | $493.75K 10-Q · filed 2011-08-15 | $493.75K 10-Q · filed 2011-08-15 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 derived: sum of 2 quarters · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 | $0.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |